Latest Capital Raises News

Page 15 of 653
TrivarX Limited reported a $1.26 million half-year loss as it completed the acquisition of Stabl-Im brain imaging IP and validated its mental health screening technology in veterans. The company raised $4.2 million to fund clinical development and expand its diagnostic portfolio.
Ada Torres
Ada Torres
24 Feb 2026
333D Limited reported a 23% increase in revenue to $588,678 for the half-year ended December 2025, despite a 92% plunge in profit after tax to a $282,030 loss. The company boosted its cash reserves significantly and initiated a strategic Bitcoin investment.
Victor Sage
Victor Sage
24 Feb 2026
QEM Limited confirms a $1.442 million capital raising via placement, addressing ASX queries on disclosure timing and compliance. The company clarifies board approvals and trading halt details, reinforcing its adherence to continuous disclosure obligations.
Maxwell Dee
Maxwell Dee
24 Feb 2026
Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.
Ada Torres
Ada Torres
24 Feb 2026
Aeris Resources has reported a robust half-year performance with a 62% jump in profit, a successful $101.6 million equity raise, and a strategic divestment of North Queensland assets. The company also announced plans to acquire Peel Mining’s South Cobar Copper Project, signaling an aggressive growth trajectory.
Maxwell Dee
Maxwell Dee
24 Feb 2026
Santana Minerals has completed a substantial A$113 million unconditional placement, with plans underway to seek shareholder approval for an additional $17 million capital raise. The move signals a significant boost to the company’s financial firepower as it advances its mining ambitions.
Maxwell Dee
Maxwell Dee
24 Feb 2026
Olympio Metals has secured binding agreements to acquire two historically high-grade silver and antimony projects in the US, backed by a $3 million capital raise including vendor participation.
Maxwell Dee
Maxwell Dee
24 Feb 2026
Tetratherix Limited reported a $4.6 million statutory loss for the first half of FY26, driven by increased R&D and manufacturing investments, while making significant progress in clinical trials and securing key global partnerships.
Ada Torres
Ada Torres
24 Feb 2026
Catalina Resources has divested its Nelson Bay River iron ore project and secured a capital injection from Newcam Metals at a significant premium, bolstering its financial position for future exploration.
Maxwell Dee
Maxwell Dee
24 Feb 2026
OncoSil Medical has reported record dose sales and cash receipts in the first half of FY26, supported by encouraging clinical trial results and expanded European market penetration.
Ada Torres
Ada Torres
24 Feb 2026
XPON Technologies has posted a strong H1 FY26 turnaround with a 58% revenue increase and a return to net profitability, driven by strategic acquisitions and operational improvements.
Sophie Babbage
Sophie Babbage
24 Feb 2026
Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.
Ada Torres
Ada Torres
24 Feb 2026